Department of Cardiology, Hayat Hospital, Malatya, Turkey.
Curr Vasc Pharmacol. 2021;19(3):243-249. doi: 10.2174/1570161118666200421142542.
Vascular diseases are the main reason for morbidity and mortality worldwide. As we know, the earlier phase of vascular diseases is endothelial dysfunction in humans, the endothelial tissues play an important role in inflammation, coagulation, and angiogenesis, via organizing ligand-receptor associations and the various mediators' secretion. We can use many inflammatory non-invasive tests (flowmediated dilatation, epicedial fat thickness, carotid-intima media thickness, arterial stiffness and anklebrachial index) for assessing the endothelial function. In addition, many biomarkers (ischemia modified albumin, pentraxin-3, E-selectin, angiopoietin, endothelial cell specific molecule 1, asymmetrical dimethylarginine, von Willebrand factor, endothelial microparticles and endothelial progenitor cells) can be used to evaluate endothelial dysfunction. We have focused on the relationship between endothelial dysfunction and inflammatory markers of vascular disease in this review.
血管疾病是全球发病率和死亡率的主要原因。众所周知,血管疾病的早期阶段是人类的血管内皮功能障碍,内皮组织在炎症、凝血和血管生成中发挥重要作用,通过组织配体-受体的关联和各种介质的分泌。我们可以使用许多炎症的非侵入性测试(血流介导的扩张、颊脂垫厚度、颈动脉内膜中层厚度、动脉僵硬度和踝臂指数)来评估内皮功能。此外,许多生物标志物(缺血修饰白蛋白、五聚素 3、E-选择素、血管生成素、内皮细胞特异性分子 1、不对称二甲基精氨酸、血管性血友病因子、内皮微颗粒和内皮祖细胞)可用于评估内皮功能障碍。在这篇综述中,我们重点关注了内皮功能障碍与血管疾病炎症标志物之间的关系。